TGFBR2 and Sepsis: Ma et al. (2019) revealed that miRNA-145 targets TGFBR2; accordingly, the knockdown of TGFBR2 or overexpression of miRNA-145 can attenuate lipopolysaccharide (LPS)-induced sepsis to improve the survival rates of septic mice, suggesting that TGFBR2 could be a potential target for treating sepsis (Ma et al., 2019).